In animal models of AD, activated M1 microglia (release of IL-1β and TNF-α) are significantly increased, while M2 microglia (release of IGF-1 and IL-10) are decreased (Wei and Li, 2022); a similar situation is observed in human AD brains (Walker and Lue, 2015). This evidence concerns the gene IGF1 and Alzheimer disease.